Vaxart Inc. (United States) is listed on the Nasdaq and has a market capitalization of $169.92 Millions, with shareholders equity totaling $87.80 Millions.
The company employs approximately 49 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Vaxart Inc. reported $237.26 Millions in revenue, generating net income of $16.33 Millions.
Key financial metrics include a P/E ratio of 10.41, a price-to-book (P/B) ratio of 1.94, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker VXRT.